SCHEMBL3979544

SCHEMBL3979544

COc1ccc(C(=O)OC(=O)c2occ(-c3ccccc3)c2-c2ccccc2)c(C(=O)NN)c1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.41
KDM4E B2RXH2 5/20 0.41
MAPT P10636 5/20 0.41
ALDH1A1 P00352 5/20 0.41
HTT P42858 4/20 0.41
HSD17B10 Q99714 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 3/20 0.39
USP2 O75604 2/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
LMNA P02545 3/20 0.39
GBA1 P04062 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RECQL P46063 1/20 0.39
GAA P10253 3/20 0.38
NPSR1 Q6W5P4 1/20 0.36
GRIA2 P42262 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3973500 0.91 ALDH1A1 (0.36) HPGDKDM4EMAPTALDH1A1HTT
SCHEMBL3977141 0.90 ALDH1A1 (0.34) HPGDKDM4EMAPTALDH1A1HTT
SCHEMBL3982964 0.90 HPGD (0.34) HPGDKDM4EMAPTALDH1A1HTT
SCHEMBL3976679 0.89 ALDH1A1 (0.34) HPGDKDM4EMAPTALDH1A1HTT
SCHEMBL3974632 0.89 CTSD (0.38) HPGDKDM4EMAPTALDH1A1HTT
SCHEMBL3975937 0.88 ALDH1A1 (0.36) HPGDKDM4EMAPTALDH1A1HTT
SCHEMBL3977002 0.88 POLB (0.37) HPGDKDM4EMAPTALDH1A1HTT
SCHEMBL3979485 0.87 MAPT (0.41) HPGDKDM4EMAPTALDH1A1HTT
SCHEMBL3978639 0.87 HTT (0.37) KDM4EMAPTALDH1A1HTTMEN1
SCHEMBL3974207 0.87 ACLY (0.37) KDM4EMAPTALDH1A1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 HPGD 299/4885KDM4E 2769/4885MAPT 4833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.